首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Fluoroquinolone use and fluoroquinolone-resistant pseudomonas aeruginosa is declining in US academic medical centre hospitals
【24h】

Fluoroquinolone use and fluoroquinolone-resistant pseudomonas aeruginosa is declining in US academic medical centre hospitals

机译:在美国学术医学中心医院中,氟喹诺酮类药物和耐氟喹诺酮类铜绿假单胞菌的使用量正在下降

获取原文
获取原文并翻译 | 示例
           

摘要

Sir,Fluoroquinolone-resistant Pseudomonas oeruginoso is associated with a negative impact on patient outcome, and treatment of these organisms can be challenging. Increases in fluoroquinolone-resistant P. oeruginoso have been reported across hospitals and these were related to fluoroquinolone use. These studies were conducted in periods during which fluoroquinolone use was increasing; more recent data show that their use appears to be stabilizing or decreasing.
机译:主席先生,对氟喹诺酮类耐药的假单胞菌对患者预后有负面影响,对这些生物的治疗可能具有挑战性。各地医院都报告了对氟喹诺酮耐药的肺炎支原体的增加,这与氟喹诺酮的使用有关。这些研究是在氟喹诺酮使用量增加的时期进行的。最近的数据表明,它们的使用正在稳定或减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号